HEADER VIRAL PROTEIN/IMMUNE SYSTEM 27-JUN-24 9CFE TITLE CRYO-EM LOCAL REFINEMENT OF ANTIBODY 19-77 IN COMPLEX WITH PREFUSION TITLE 2 SARS-COV-2 SPIKE GLYCOPROTEIN RBD COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: C; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_TAXID: 2697049; SOURCE 15 GENE: S, 2; SOURCE 16 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS NEUTRALIZING ANTIBODY, VIRAL FUSION PROTEIN, SARS-COV-2, VIRAL KEYWDS 2 PROTEIN-IMMUNE SYSTEM COMPLEX, VIRAL PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR R.G.CASNER,L.SHAPIRO REVDAT 3 01-OCT-25 9CFE 1 JRNL REVDAT 2 24-SEP-25 9CFE 1 JRNL REVDAT 1 02-JUL-25 9CFE 0 JRNL AUTH Q.WANG,Y.GUO,R.G.CASNER,J.YU,M.S.NAIR,J.HO,E.R.REDDEM, JRNL AUTH 2 I.A.MELLIS,M.WU,C.C.TZANG,H.HONG,Y.HUANG,L.SHAPIRO,L.LIU, JRNL AUTH 3 D.D.HO JRNL TITL OPTIMIZING A HUMAN MONOCLONAL ANTIBODY FOR BETTER JRNL TITL 2 NEUTRALIZATION OF SARS-COV-2. JRNL REF NAT COMMUN V. 16 6195 2025 JRNL REFN ESSN 2041-1723 JRNL PMID 40615407 JRNL DOI 10.1038/S41467-025-61472-Z REMARK 2 REMARK 2 RESOLUTION. 3.03 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : LEGINON, PHENIX, CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.030 REMARK 3 NUMBER OF PARTICLES : 329845 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 9CFE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-JUN-24. REMARK 100 THE DEPOSITION ID IS D_1000285014. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : ANTIBODY 19-77 IN COMPLEX WITH REMARK 245 PREFUSION SARS-COV-2 SPIKE REMARK 245 GLYCOPROTEIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 800.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 5800.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP C 364 HG SER C 366 1.57 REMARK 500 OD1 ASP A 72 HG SER A 74 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 31 NE - CZ - NH2 ANGL. DEV. = 3.0 DEGREES REMARK 500 ARG A 66 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG A 97 NE - CZ - NH2 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG B 61 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG B 91 NE - CZ - NH2 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG C 403 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 ARG C 454 NE - CZ - NH2 ANGL. DEV. = 3.3 DEGREES REMARK 500 PRO C 521 CA - N - CD ANGL. DEV. = -8.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 12 -156.75 -139.19 REMARK 500 SER A 114 -149.76 -165.43 REMARK 500 PRO B 8 -179.92 -69.88 REMARK 500 SER B 12 53.77 -143.35 REMARK 500 LEU B 47 -60.03 -101.41 REMARK 500 ALA B 51 -11.41 59.62 REMARK 500 SER B 52 -25.09 -159.81 REMARK 500 GLU B 68 -79.62 66.94 REMARK 500 ASP B 93 59.21 -119.25 REMARK 500 ILE B 107 -69.03 -127.56 REMARK 500 ASN C 343 41.54 -78.49 REMARK 500 VAL C 362 41.61 -158.99 REMARK 500 PHE C 377 59.92 -146.67 REMARK 500 ASN C 394 135.03 -171.20 REMARK 500 ASN C 422 -51.75 -131.49 REMARK 500 PHE C 464 16.90 51.49 REMARK 500 PRO C 479 161.05 -49.95 REMARK 500 CYS C 480 -36.43 -138.12 REMARK 500 PHE C 486 109.96 -55.11 REMARK 500 THR C 500 -118.48 47.92 REMARK 500 HIS C 519 12.27 90.19 REMARK 500 PRO C 521 76.73 28.97 REMARK 500 THR C 523 45.09 -75.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG C 403 0.14 SIDE CHAIN REMARK 500 TYR C 421 0.11 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-45543 RELATED DB: EMDB REMARK 900 CRYO-EM LOCAL REFINEMENT OF ANTIBODY 19-77 IN COMPLEX WITH REMARK 900 PREFUSION SARS-COV-2 SPIKE GLYCOPROTEIN RBD DBREF 9CFE A 1 115 PDB 9CFE 9CFE 1 115 DBREF 9CFE B 1 108 PDB 9CFE 9CFE 1 108 DBREF 9CFE C 335 527 UNP P0DTC2 SPIKE_SARS2 335 527 SEQRES 1 A 115 GLU VAL GLN VAL VAL GLU SER GLY GLY GLY LEU ILE GLN SEQRES 2 A 115 PRO GLY GLY SER LEU ARG LEU SER CYS THR ALA SER GLU SEQRES 3 A 115 LEU ILE ILE SER ARG ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 A 115 ALA PRO GLY LYS GLY LEU GLU TRP LEU SER VAL ILE TYR SEQRES 5 A 115 PRO GLY GLY SER SER PHE TYR THR ASP SER LEU LYS GLY SEQRES 6 A 115 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 A 115 TYR LEU GLN MET ASN ARG LEU GLY VAL GLU ASP THR ALA SEQRES 8 A 115 ILE TYR TYR CYS VAL ARG ASP ALA PRO SER GLU SER ASP SEQRES 9 A 115 TRP GLY GLN GLY THR LEU VAL THR VAL SER SER SEQRES 1 B 108 GLU ILE VAL LEU THR GLN SER PRO ALA THR LEU SER LEU SEQRES 2 B 108 PHE PRO GLY GLU ARG ALA THR LEU SER CYS ARG ALA SER SEQRES 3 B 108 GLN ASN ILE GLY HIS PHE LEU THR TRP TYR GLN GLN LYS SEQRES 4 B 108 PRO GLY GLN ALA PRO ARG LEU LEU ILE TYR ASP ALA SER SEQRES 5 B 108 ASN ARG ALA THR GLY VAL PRO ALA ARG PHE SER GLY SER SEQRES 6 B 108 GLY SER GLU THR GLU PHE THR LEU THR ILE SER SER LEU SEQRES 7 B 108 GLY PRO GLU ASP PHE ALA VAL TYR TYR CYS GLN GLU ARG SEQRES 8 B 108 SER ASP TRP PRO ARG GLY THR PHE GLY GLN GLY THR LYS SEQRES 9 B 108 VAL GLU ILE LYS SEQRES 1 C 193 LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR ARG PHE SEQRES 2 C 193 ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SER ASN SEQRES 3 C 193 CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER ALA SER SEQRES 4 C 193 PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO THR LYS SEQRES 5 C 193 LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SER SEQRES 6 C 193 PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA PRO SEQRES 7 C 193 GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR LYS LEU SEQRES 8 C 193 PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SER SEQRES 9 C 193 ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR ASN TYR SEQRES 10 C 193 LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO PHE SEQRES 11 C 193 GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SER SEQRES 12 C 193 THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS TYR PHE SEQRES 13 C 193 PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN GLY VAL SEQRES 14 C 193 GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE GLU SEQRES 15 C 193 LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO HELIX 1 AA1 GLY A 86 THR A 90 5 5 HELIX 2 AA2 GLY B 79 PHE B 83 5 5 HELIX 3 AA3 PRO C 337 ASN C 343 1 7 HELIX 4 AA4 SER C 349 TRP C 353 5 5 HELIX 5 AA5 ASP C 364 ASN C 370 1 7 HELIX 6 AA6 SER C 383 LEU C 387 5 5 HELIX 7 AA7 ASP C 405 ILE C 410 5 6 HELIX 8 AA8 GLY C 416 ASN C 422 1 7 HELIX 9 AA9 SER C 438 SER C 443 1 6 HELIX 10 AB1 GLY C 502 TYR C 505 5 4 SHEET 1 AA1 4 VAL A 4 SER A 7 0 SHEET 2 AA1 4 LEU A 18 ALA A 24 -1 O THR A 23 N VAL A 5 SHEET 3 AA1 4 THR A 77 MET A 82 -1 O MET A 82 N LEU A 18 SHEET 4 AA1 4 PHE A 67 ASP A 72 -1 N SER A 70 O TYR A 79 SHEET 1 AA2 6 GLY A 10 ILE A 12 0 SHEET 2 AA2 6 THR A 109 VAL A 113 1 O THR A 112 N GLY A 10 SHEET 3 AA2 6 ALA A 91 ALA A 99 -1 N TYR A 93 O THR A 109 SHEET 4 AA2 6 TYR A 33 GLN A 39 -1 N VAL A 37 O TYR A 94 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O GLU A 46 N ARG A 38 SHEET 6 AA2 6 SER A 57 TYR A 59 -1 O PHE A 58 N VAL A 50 SHEET 1 AA3 4 GLY A 10 ILE A 12 0 SHEET 2 AA3 4 THR A 109 VAL A 113 1 O THR A 112 N GLY A 10 SHEET 3 AA3 4 ALA A 91 ALA A 99 -1 N TYR A 93 O THR A 109 SHEET 4 AA3 4 GLU A 102 TRP A 105 -1 O GLU A 102 N ALA A 99 SHEET 1 AA4 4 LEU B 4 SER B 7 0 SHEET 2 AA4 4 ALA B 19 ALA B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA4 4 GLU B 70 ILE B 75 -1 O PHE B 71 N CYS B 23 SHEET 4 AA4 4 PHE B 62 SER B 67 -1 N SER B 65 O THR B 72 SHEET 1 AA5 6 THR B 10 LEU B 11 0 SHEET 2 AA5 6 THR B 103 VAL B 105 1 O LYS B 104 N LEU B 11 SHEET 3 AA5 6 VAL B 85 GLU B 90 -1 N TYR B 86 O THR B 103 SHEET 4 AA5 6 LEU B 33 GLN B 38 -1 N TYR B 36 O TYR B 87 SHEET 5 AA5 6 ARG B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA5 6 ASN B 53 ARG B 54 -1 O ASN B 53 N TYR B 49 SHEET 1 AA6 5 ASN C 354 ILE C 358 0 SHEET 2 AA6 5 ASN C 394 ARG C 403 -1 O ALA C 397 N LYS C 356 SHEET 3 AA6 5 PRO C 507 GLU C 516 -1 O TYR C 508 N ILE C 402 SHEET 4 AA6 5 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 5 AA6 5 THR C 376 TYR C 380 -1 N TYR C 380 O GLY C 431 SHEET 1 AA7 2 LEU C 452 ARG C 454 0 SHEET 2 AA7 2 LEU C 492 SER C 494 -1 O GLN C 493 N TYR C 453 SSBOND 1 CYS C 336 CYS C 361 1555 1555 2.02 SSBOND 2 CYS C 379 CYS C 432 1555 1555 2.04 SSBOND 3 CYS C 391 CYS C 525 1555 1555 2.04 SSBOND 4 CYS C 480 CYS C 488 1555 1555 2.02 CISPEP 1 SER B 7 PRO B 8 0 -11.86 CISPEP 2 TRP B 94 PRO B 95 0 -4.83 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 TER 1751 SER A 115 TER 3407 LYS B 108 TER 6385 PRO C 527 CONECT 3434 3837 CONECT 3837 3434 CONECT 4106 4910 CONECT 4285 6359 CONECT 4910 4106 CONECT 5678 5781 CONECT 5781 5678 CONECT 6359 4285 MASTER 197 0 0 10 31 0 0 6 3252 3 8 33 END